Latest News

Alliance Pharma plc - R&D Tax Credits
1 July 2008
RNS Number : 9638X
Alliance Pharma PLC
01 July 2008


For immediate release   1 July 2008

ALLIANCE PHARMA PLC
('Alliance Pharma' or 'the Company')

Tax Credit Claims

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that it is making Research & Development Tax Credit claims in respect of the 2006 and 2007 financial years, which could result in cash payments to the Company from HM Revenue & Customs of around £0.7m. These tax credit cash payments are likely to have a positive impact on the Company's reported profits in 2008. Neither claim has yet been finally agreed with HM Revenue and Customs, but Alliance Pharma has received £440,000 cash in respect of the claim for 2006.

The Company will provide a pre-close trading update in early July ahead of the announcement of its interim results for the six months ended 30 June 2008, which is scheduled for 10 September 2008.


For further information:

Alliance Pharma plc                  + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk

Buchanan Communications        + 44 (0) 20 7466 5000
Mark Court / Rebecca Skye Dietrich

Numis Securities                       + 44 (0) 20 7260 1000
David Poutney / Michael Meade / Brent Nabbs


This information is provided by RNS
The company news service from the London Stock Exchange